scholarly article | Q13442814 |
P50 | author | Antonella Zucchetto | Q42703050 |
Silvia Martinelli | Q45958982 | ||
Giovanni Del Poeta | Q56950902 | ||
Davide Rossi | Q89878155 | ||
Antonio Cuneo | Q91310932 | ||
Carla Guarnotta | Q114406100 | ||
Elisa Sozzi | Q114441832 | ||
Rita Santachiara | Q114528473 | ||
Stefania Fiorcari | Q114528530 | ||
Patrizia Zucchini | Q114528532 | ||
Gianluca Gaidano | Q30303486 | ||
Francesco Forconi | Q30303490 | ||
Valter Gattei | Q30303512 | ||
Gian Matteo Rigolin | Q37830534 | ||
Claudio Tripodo | Q38317827 | ||
Rossana Maffei | Q38326918 | ||
Roberto Marasca | Q38326950 | ||
P2093 | author name string | Giuseppe Torelli | |
Valeria Coluccio | |||
Ilaria Castelli | |||
Giovanna Leonardi | |||
Marcella Fontana | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
lymphocyte | Q715347 | ||
P304 | page(s) | 584-592 | |
P577 | publication date | 2010-04-09 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. | |
P478 | volume | 116 |
Q37192643 | ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia. |
Q41208882 | Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis |
Q47119323 | Angiogenesis in adenosquamous cancer of pancreas |
Q37043828 | Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer |
Q28287317 | Angiopoietin signaling in the vasculature |
Q48330774 | Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement |
Q41758452 | Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis |
Q84617608 | Angiopoietin-2 in CLL |
Q40535831 | Angiopoietins Modulate Survival, Migration, and the Components of the Ang-Tie2 Pathway of Chronic Lymphocytic Leukaemia (CLL) Cells In Vitro |
Q41045903 | Association of β2-microglobulin with the prognosis of non-Hodgkin's lymphoma: a meta analysis. |
Q46211892 | Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population |
Q26830323 | Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia |
Q28539394 | Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor |
Q37174690 | Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial |
Q33416596 | FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia |
Q36069142 | Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis |
Q41374499 | MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia |
Q46666106 | Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report |
Q36006453 | Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells. |
Q36121903 | Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis |
Q37978344 | RNA-based markers as prognostic factors in chronic lymphocytic leukemia |
Q38101997 | Targeting angiopoietin-2 signaling in cancer therapy |
Q37774852 | Targeting the ANGPT-TIE2 pathway in malignancy |
Q37859253 | The bone marrow stroma in hematological neoplasms--a guilty bystander. |
Q36967153 | The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation. |
Q26753835 | The progress of angiogenic factors in the development of leukemias |
Q39321127 | Therapeutic targeting of the angiopoietin-TIE pathway |
Search more.